Skip to content

Metabolic Mechanism and Prevention Strategy of CKD and relative vascular complications

Metabolic Mechanism and Prevention Strategy of CKD and relative vascular complications

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300071332
Enrollment
Unknown
Registered
2023-05-11
Start date
2023-05-20
Completion date
Unknown
Last updated
2023-06-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic kidney disease

Interventions

stage1-2 CKD patients:N/A
stage3 CKD patients:N/A
stage4 CKD patients:N/A
stage5 CKD patients:N/A
Healthy control group:N/A

Sponsors

Peking Union Medical College Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: ? Age 18-65 years old, gender unlimited; ? Patients who completed renal biopsy: the number of PAS stained glomeruli in renal biopsy tissue was not less than 8, and pathological diagnosis was made jointly by two experienced renal pathologists. Pathological diagnosis was consistent with IgAN or pMN, HTN benign arteriolar sclerosis or typical/atypical DN. If there is no renal biopsy data in the metabolic nephropathy group, the patient can be diagnosed as hypertension-related kidney damage or diabetic nephropathy by two clinical physicians. ? 1-year follow-up can be completed; ? Patients or family members can understand the study protocol and are willing to participate in the study, and provide written informed consent.

Exclusion criteria

Exclusion criteria: (1) Combined with secondary factors that may lead to similar or even pathological changes (such as Henoschonlein purpura nephritis, nephritis secondary to autoimmune disease, inflammatory bowel disease, virus-associated nephritis and cirrhosis of the liver, drug-induced kidney damage, etc.), combined with primary renal diseases other than IgAN or pMN (such as MCD, FSGS); ? Pregnant or lactating women; ? Patients with serious mental illness or malignant tumor; ? Patients undergoing major operations within six months; ? Can't keep a food diary.

Design outcomes

Primary

MeasureTime frame
lipid files;Serum creatinine;

Secondary

MeasureTime frame
Carotid intima-media thickness;Vascular elasticity;Dietary structure characteristics;Cognitive Function;

Countries

China

Contacts

Public ContactKe Zheng

Peking Union Medical College Hospital

kellyz_0_67@163.com+86 135 2007 0767

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026